Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
Companexia provides businesses with the tools to research, validate, and analyze companies by utilizing data from official public registries. This platform consolidates essential company information into a single interface, encompassing aspects such as legal status, registration information, details about directors and officers, ownership structures, financial data, filing histories, and associated entities.
Tailored for compliance teams, legal experts, due diligence analysts, investors, and B2B teams, it enables users to evaluate companies swiftly and confidently. Rather than manually navigating through various registries, users can conduct a search for a company and access all crucial details within a streamlined process.
Common applications of Companexia include conducting thorough company due diligence, performing Know Your Business (KYB) checks, investigating ownership structures, carrying out financial assessments, assessing risks, and undertaking general company verification, making it an invaluable resource for informed decision-making. Additionally, the ease of access to comprehensive data significantly enhances the efficiency of the verification process for its users.
Description
EquiReason serves as a comprehensive platform for equity research and market intelligence, catering to self-directed investors, independent analysts, and research teams alike. By integrating SEC filings, XBRL financial data, earnings-call transcripts, and extensive market information, it empowers users to analyze financial performance, ownership trends, and overall company exposure. The platform meticulously tracks market events through economic channels, linking them to potentially impacted companies and offering a verdict for each, complete with supporting and counter-arguments. Users can access a variety of research perspectives, which include financial statements, valuation insights, insider and institutional activities, segment revenue details, and alerts specific to each company, with all evidence connected to its original source. Accessible via both web and iPhone app, EquiReason features a free plan alongside paid research options, ensuring users have the necessary tools for informed decision-making. Importantly, the platform focuses on providing research and decision support rather than direct investment advice, enabling users to navigate the complexities of the market with greater confidence.
API Access
Has API
No
API Access
Has API
Yes
Screenshots View All
No images available
Screenshots View All
No images available
Integrations
No details available.
Integrations
No details available.
Pricing Details
Free
Free Trial
No
Free Version
Yes
Pricing Details
$49/month
Free plan available. Analyst is $49/month; Research Pro is $89/month. Annual billing is ten months for twelve. Research Pro has a seven-day trial with no card required.
Free Trial
Yes
Free Version
Yes
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
Yes
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Customer Support
Business Hours
No
Live Rep (24/7)
No
Online Support
No
Customer Support
Business Hours
No
Live Rep (24/7)
No
Online Support
No
Types of Training
Training Docs
Yes
Webinars
No
Live Training (Online)
No
In Person
No
Types of Training
Training Docs
No
Webinars
No
Live Training (Online)
No
In Person
No
Vendor Details
Company Name
Companexia
Founded
2026
Country
United States
Website
companexia.com/en
Vendor Details
Company Name
EquiReason
Founded
2026
Country
Turkey
Website
equireason.com